The Fuel Behind the Feeling: What a New Trial Reveals About Creatine, CBT and the Energy of Recovery

A Singular Point of View

A cheap, familiar supplement — the sort sold in gym bags rather than pharmacies — appeared to help talking therapy lift people out of depression faster than therapy alone. The trial is small and the science is early, but the finding is quietly, genuinely hopeful.

Think of the mind as a lamp. We tend to worry endlessly about the shape of the flame — how brightly it burns, how it gutters in a draught — and far less about the quiet business of the oil that feeds it. Yet a lamp with no fuel cannot be talked into shining. It can only be refilled. A new clinical trial, small but carefully done, asks a question that sits right at that overlooked join between chemistry and conversation: what happens to a course of talking therapy when we also top up the brain’s fuel? The answer, though early and far from settled, is the kind that makes you sit up a little straighter.

A humble supplement meets a trusted therapy

The supplement in question is creatine — a compound most people file alongside protein shakes and pre-workout powders rather than the consulting room. Our bodies make it naturally, and we take in a little more from meat and fish; its everyday job is to help shuttle energy around cells that work hard, muscle cells especially. But the brain is one of the hungriest organs we own, and researchers have wondered for years whether the same molecule that helps a sprinter’s legs might also help an exhausted mind.

The therapy needs less introduction. Cognitive behavioural therapy (CBT, a structured, practical talking treatment that helps a person notice the thoughts feeding their low mood and gently test them against reality) is one of the most studied psychological treatments in the world, and for good reason: it works for a great many people. But it does not work for everyone, and it does not always work quickly. That gap — the space between “some improvement” and “genuinely better” — is where this trial went looking.

What the researchers actually found

Published in the journal European Neuropsychopharmacology in early 2025, the study was led by Sherpa and colleagues and carried out in an under-resourced setting, where affordable, accessible treatments matter enormously. One hundred adults living with depression — about half of them women, most around thirty years old — were randomly split into two groups. Both received CBT. One group also took five grams of creatine monohydrate a day; the other took an identical-looking placebo. Crucially, neither the participants nor the people assessing them knew who was taking what. That is what “double-blind, randomised, placebo-controlled” means — the gold-standard design for stopping our hopes and expectations from quietly shaping the result.

Over eight weeks, both groups improved, which is itself worth pausing on: CBT was helping people on both sides of the study. But the group taking creatine improved considerably more. Depression was measured with the PHQ-9 (a widely used nine-question questionnaire scored from 0 to 27, where a higher number means heavier symptoms). In the creatine group, average scores fell from around 17.8 — firmly in the moderate-to-severe range — to about 5.8, which sits close to the threshold for minimal symptoms. The placebo group, receiving the very same therapy, dropped to around 11.9. When the researchers adjusted the figures, the gap between the two groups came out at an average of roughly five points on the scale (an adjusted mean difference of −5.12, with a 95% confidence interval from −7.20 to −3.52; p < 0.05 — statistician’s shorthand for a result unlikely to be down to chance alone). Put plainly, adding a modest daily dose of a cheap, familiar supplement appeared to give the talking therapy a meaningful lift.

Why might a muscle supplement touch the mind?

The idea is less strange than it first sounds. Depression is increasingly understood not only as a matter of mood and thought but partly as a problem of energy — of brain cells struggling to power themselves efficiently. Creatine plays a direct role in how cells store and release energy, buffering the little bursts of power that neurons draw on constantly. The working theory is that by shoring up this cellular energy supply, creatine may make the brain better able to do the demanding work that recovery — and CBT in particular — asks of it. Therapy is effortful. It requires attention, memory and the willingness to try new patterns of thinking. A better-fuelled brain may simply be better placed to take that work on.

An honest look at the limits

Here I want to slow down, because hope without honesty helps no one. The researchers themselves are admirably clear that this was a pilot study — a first, exploratory step designed to test whether a bigger trial is worth running. The numbers involved were small. It ran for only eight weeks, so we do not know whether the benefit lasts. It was conducted in one particular setting, and results do not always travel neatly from one population to another. The authors describe their own findings as “hypothesis-generating” and call, quite rightly, for larger and longer trials before anyone draws firm conclusions.

What this study is not is a licence to swap therapy for a tub of powder, or to treat creatine as a stand-alone cure. In this trial creatine was an add-on — a partner to CBT, not a replacement for it. Depression is a serious condition, and anyone struggling deserves proper support, not a supplement bought on a hunch. Read in that spirit, though, the study is genuinely encouraging: it points to a low-cost, low-risk way of making a proven therapy work a little harder — exactly the kind of news that matters most in places, and for people, where resources are stretched thin.

How to think about this sensibly

If this research has caught your attention — perhaps for yourself, perhaps for someone you love — the most useful thing is not to rush, but to take a few measured steps.

• Put the therapy first. The star of this study was CBT; the creatine was a support act. If low mood is weighing on you, the single most valuable move is to speak to your GP or an NHS talking-therapies service about accessing proper psychological support.
• Talk to a professional before adding a supplement. Creatine is widely regarded as safe for most healthy adults, but “most” is not “all”. A quick word with your GP or a pharmacist — particularly if you take other medication or have any kidney concerns — is a small step that protects you.
• Understand the dose used. The trial used five grams a day of plain creatine monohydrate, the simplest and best-studied form. More is not better here; doubling up does not double the benefit.
• Drink enough water. Creatine draws a little extra water into your cells, so staying well hydrated is a sensible habit alongside it.
• Give it time, and keep noticing. A change in mood is rarely a lightning bolt. Track how you feel over weeks, ideally alongside a therapist or GP who can help you read the pattern honestly.

A wider lesson for restless minds

There is a thread here that reaches beyond depression. Those of us who live with, or love someone with, ADHD (attention-deficit/hyperactivity disorder) know that the brain’s energy and its willingness to engage are not always things we can summon by force of will. The deeper message of this research is not really about one supplement at all. It is that the mind is embodied — that what we eat, how we sleep, how we fuel the physical organ doing the thinking can quietly shape whether our best psychological efforts take root. That is not a reason to abandon therapy in favour of chemistry, but an invitation to treat mind and body as the single, connected system they have always been.

Conclusion

One careful, hopeful study will not rewrite the textbooks, and it should not. But it offers something valuable all the same: a reminder that recovery is rarely about a single heroic intervention, and far more often about many small, sensible things stacked patiently together. Good therapy. A well-fuelled brain. Enough water, enough sleep, enough kindness towards yourself to keep going while the work does its quiet work. So here is the nudge to carry away: if you have been waiting for one perfect answer before you begin, stop waiting. Start today with the step in front of you — a phone call, an appointment, a conversation — and let the small things do their patient, cumulative good.

---

Source: Sherpa et al., “Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area,” European Neuropsychopharmacology, vol. 90, January 2025. Reporting via Daily Beirut, 16 August 2026.